Published On: Fri, May 28th, 2021

Bharat Biotech signs contract manufacturing deal for Covaxin with Gujarat consortium

Tagged with: | | | | | | | |

Bharat Biotech International has signed a contract manufacturing agreement with the Gujarat Covid Vaccine Consortium (GCVC) pertaining to the drug substance for its vaccine against Covid-19.

The Gujarat Covid Vaccine Consortium comprises the Gujarat-government owned (GBRC), Hester Biosciences, and .

As per the agreement, Bharat Biotech will provide the technology for the production of the drug substance for the Covid vaccine.

Bharat Biotech signs contract manufacturing deal for Covaxin with Gujarat Covid Vaccine Consortium

Bharat Biotech signs contract manufacturing deal for Covaxin with Gujarat Covid Vaccine Consortium. Photo courtesy of DTM/Wikimedia Commons.

Gujarat Biotechnology Research Centre will play the role of an advisor and mentor, and will enable the technology transfer from the .

On the other hand, Hester Biosciences will provide the complete infrastructure at its manufacturing plant in Gujarat for the production of the Covaxin drug substance. Omnibrx Biotechnologies will play the role of a technology support partner.

The whole process is facilitated by the Indian government’s Department of Biotechnology. The drug substance is expected to be available from August 2021, which will be delivered to Bharat Biotech for producing Covaxin.

Hester Biosciences has estimated an outlay of INR 40 crores for the contract manufacturing project.

The company said that the proposed production activity at its plant will not affect any manufacturing or marketing forecasts of its on-going business, for the financial year 2021-2022.

Related posts

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Recent Posts